GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aclarion Inc (FRA:IT20) » Definitions » Net Interest Income (for Banks)

Aclarion (FRA:IT20) Net Interest Income (for Banks)


View and export this data going back to 2025. Start your Free Trial

What is Aclarion Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Aclarion Business Description

Comparable Companies
Traded in Other Exchanges
Address
8181 Arista Place, Suite 100, Broomfield, CO, USA, 80021
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.